Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency

Journal of Nuclear Cardiology

Volumn 13, Issue 3, 2006, Pages 369-377

  de las Fuentes, Lisa ^a   Soto, Pablo F ^c   Cupps, Brian P ^b   Pasque, Michael K ^b   Herrero, Pilar ^c   Gropler, Robert J ^c   Waggoner, Alan D ^a   Dávila Román, Victor G ^a  

^a Cardiovascular Imaging and Clinical Research Core Laboratory   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension induced left ventricular hypertrophy; myocardial efficiency; myocardial fatty acid metabolism

Indexed keywords

CARBON 11; FATTY ACID; OXYGEN; PALMITIC ACID;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL;

AGED; CALIBRATION; COHORT STUDIES; FATTY ACIDS; FEMALE; HEART; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; PALMITIC ACIDS; POSITRON-EMISSION TOMOGRAPHY;

EID: 33646918913     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.01.021     Document Type: Article

References (48)

1. Fields L.E., Burt V.L., Cutler J.A., Hughes J., Roccella E.J., and Sorlie P. The burden of adult hypertension in the United States 1999 to 2000. a rising tide. Hypertension 44 (2004) 398-404
2. Yonekura Y., Brill A.B., Som P., Yamamoto K., Srivastava S.C., Iwai J., et al. Regional myocardial substrate uptake in hypertensive rats. a quantitative autoradiographic measurement. Science 227 (1985) 1494-1496
3. Taegtmeyer H., and Overturf M.L. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 11 (1988) 416-426
4. Kagaya Y., Kanno Y., Takeyama D., Ishide N., Maruyama Y., Takahashi T., et al. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study. Circulation 81 (1990) 1353-1361
5. Sack M.N., Harrington L.S., Jonassen A.K., Mjos O.D., and Yellon D.M. Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats. Cardiovasc Drugs Ther 14 (2000) 31-39
6. Young M.E., Laws F.A., Goodwin G.W., and Taegtmeyer H. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem 276 (2001) 44390-44395
7. Kantor P.F., Robertson M.A., Coe J.Y., and Lopaschuk G.D. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism. J Am Coll Cardiol 33 (1999) 1724-1734
8. Sack M.N., Rader T.A., Park S., Bastin J., McCune S.A., and Kelly D.P. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94 (1996) 2837-2842
9. Christe M.E., and Rodgers R.L. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 26 (1994) 1371-1375
10. Kelly D.P., and Strauss A.W. Inherited cardiomyopathies. N Engl J Med 330 (1994) 913-919
11. Bergmann S.R., Weinheimer C.J., Markham J., and Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 37 (1996) 1723-1730
12. Soto P.F., Herrero P., Kates A.M., Dence C.S., Ehsani A.A., Davila-Roman V., et al. Impact of aging on myocardial metabolic response to dobutamine. Am J Physiol Heart Circ Physiol 285 (2003) H2158-H2164
13. Peterson L.R., Herrero P., Schechtman K.B., Racette S.B., Waggoner A.D., Kisrieva-Ware Z., et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109 (2004) 2191-2196
14. Bergmann S.R., Herrero P., Markham J., Weinheimer C.J., and Walsh M.N. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 14 (1989) 639-652
15. Lee H.H., Davila-Roman V.G., Ludbrook P.A., Courtois M., Walsh J.F., Delano D.A., et al. Dependency of contractile reserve on myocardial blood flow. implications for the assessment of myocardial viability with dobutamine stress echocardiography. Circulation 96 (1997) 2884-2891
16. Buck A., Wolpers H.G., Hutchins G.D., Savas V., Mangner T.J., Nguyen N., et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 32 (1991) 1950-1957
17. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al., American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
18. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413-2446
19. Ungacta F.F., Davila-Roman V.G., Moulton M.J., Cupps B.P., Moustakidis P., Fishman D.S., et al. MRI-radiofrequency tissue tagging in patients with aortic insufficiency before and after operation. Ann Thorac Surg 65 (1998) 943-950
20. Cupps B.P., Moustakidis P., Pomerantz B.J., Vedala G., Scheri R.P., Kouchoukos N.T., et al. Severe aortic insufficiency and normal systolic function. determining regional left ventricular wall stress by finite-element analysis. Ann Thorac Surg 76 (2003) 668-675
21. Stefadouros M.A., Dougherty M.J., Grossman W., and Craige E. Determination of systemic vascular resistance by a noninvasive technic. Circulation 47 (1973) 101-107
22. Colan S.D., Borow K.M., and Neumann A. Use of the calibrated carotid pulse tracing for calculation of left ventricular pressure and wall stress throughout ejection. Am Heart J 109 (1985) 1306-1310
23. Drzewiecki G.M., Melbin J., and Noordergraaf A. Arterial tonometry. review and analysis. J Biomech 16 (1983) 141-152
24. Creswell L.L., Moulton M.J., Wyers S.G., Pirolo J.S., Fishman D.S., Perman W.H., et al. An experimental method for evaluating constitutive models of myocardium in in vivo hearts. Am J Physiol 267 (1994) H853-H863
25. Moulton M.J., Creswell L.L., Downing S.W., Actis R.L., Myers K.W., Szabo B.A., et al. Ventricular interaction in the pathologic heart. A model based study. ASAIO J 40 (1994) M773-M783
26. Szabo B.A., and Babuéska I. Finite element analysis (1991), Wiley, New York
27. Maniar H.S., Cupps B.P., Potter D.D., Moustakidis P., Camillo C.J., Chu C.M., et al. Ventricular function after coronary artery bypass grafting. evaluation by magnetic resonance imaging and myocardial strain analysis. J Thorac Cardiovasc Surg 128 (2004) 76-82
28. Morgan C.R., and Lazarow A. Immunoassay of insulin using a two-antibody system. Proc Soc Exp Biol Med 110 (1962) 29-32
29. Davila-Roman V.G., Vedala G., Herrero P., de las Fuentes L., Rogers J.G., Kelly D.P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 271-277
30. de las Fuentes L., Herrero P., Peterson L.R., Kelly D.P., Gropler R.J., and Davila-Roman V.G. Myocardial fatty acid metabolism. independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 41 (2003) 83-87
31. Takahashi R., Okumura K., Matsui H., Saburi Y., Kamiya H., Masubara K., et al. Impact of alpha-tocopherol on cardiac hypertrophy due to energy metabolism disorder. the involvement of 1,2-diacylglycerol. Cardiovasc Res 58 (2003) 565-574
32. Rupp H., Elimban V., and Dhalla N.S. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J 6 (1992) 2349-2353
33. Kusaka Y., Tanaka T., Okamoto F., Terasaki F., Matsunaga Y., Miyazaki H., et al. Effect of sulfo-N-succinimidyl palmitate on the rat heart. myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol 27 (1995) 1605-1612
34. Tanaka T., Sohmiya K., and Kawamura K. Is cd36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?. J Mol Cell Cardiol 29 (1997) 121-127
35. Moalic J.M., Charlemagne D., Mansier P., Chevalier B., and Swynghedauw B. Cardiac hypertrophy and failure-a disease of adaptation. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity. Circulation 87 (1993) IV21-IV26
36. Wittels B., and Spann Jr. J.F. Defective lipid metabolism in the failing heart. J Clin Invest 47 (1968) 1787-1794
37. Bishop S.P., and Altschuld R.A. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 218 (1970) 153-159
38. Feinendegen L.E., Henrich M.M., Kuikka J.T., Thompson K.H., Vester E.G., and Strauer B. Myocardial lipid turnover in dilated cardiomyopathy. a dual in vivo tracer approach. J Nucl Cardiol 2 (1995) 42-52
39. Massie B.M., Schaefer S., Garcia J., McKirnan M.D., Schwartz G.G., Wisneski J.A., et al. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation 91 (1995) 1814-1823
40. Goldstein R.A., Klein M.S., Welch M.J., and Sobel B.E. External assessment of myocardial metabolism with C-11 palmitate in vivo. J Nucl Med 21 (1980) 342-348
41. Kelly D.P., Mendelsohn N.J., Sobel B.E., and Bergmann S.R. Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency). Am J Cardiol 71 (1993) 738-744
42. Kurata C., Tawarahara K., Taguchi T., Aoshima S., Kobayashi A., Yamazaki N., et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 33 (1992) 6-13
43. Takeishi Y., Chiba J., Abe S., Tonooka I., Komatani A., and Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-r,s-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 19 (1992) 775-782
44. Yazaki Y., Isobe M., Takahashi W., Kitabayashi H., Nishiyama O., Sekiguchi M., et al. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT. correlation with clinicopathological findings and clinical course. Heart 81 (1999) 153-159
45. Nakayama H., Morozumi T., Nanto S., Shimonagata T., Ohara T., Takano Y., et al. Abnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heart. Jpn Circ J 65 (2001) 783-787
46. Laine H., Katoh C., Luotolahti M., Yki-Jarvinen H., Kantola I., Jula A., et al. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation 100 (1999) 2425-2430
47. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M., et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 75 (1985) 809-817
48. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., et al. Insulin resistance in essential hypertension. N Engl J Med 317 (1987) 350-357